1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit

changes in network OPEX ( excluding cost of TOT partnership + 10% YoY, -1.6% QoQ) and SG&A (+7.1% YoY, -2.6% QoQ) . Net profit was reported at Bt7,615mn, decreasing 5.3% YoY due to higher network and

pushing SG&A expenses to increase 5.5% YoY. 1H22 EBITDA declined -1.8% YoY as a result of an improvement in total revenue offset by an increase in SG&A. Net profit reported at Bt12,616mn, declined by -7.8

1.3 Gain (loss) on Securities trading 1.4 Gain (loss) on Derivatives trading 1.5 Interest and dividend 1.6 Interest on margin loans 1.7 Share of profit of subsidiaries and associates 1.8 Others incomes

Share of profit of subsidiaries and associates 1.8 Others incomes Total Income 2. Expenses 2.1 Expenses on Borrowing 2.2 Fee and Service Expenses 2.3 Bad debt and doubtful accounts 2.4 Shares of loss of

margin loans 1.7 Share of profit of subsidiaries and associates 1.8 Others incomes Total Income 2. Expenses 2.1 Expenses on Borrowing 2.2 Fee and Service Expenses 2.3 Bad debt and doubtful accounts 2.4

. Benefits which shareholders will receive from the capital increase/share allotment 7.1. Dividend policy The Company has policy to pay dividend at the rate of not less than 50% of net profit of the

)% 216 201 7% Feedstock 148 151 114 30% 569 410 39% Core EBIT 288 230 155 86% 871 551 58% Core Net Profit after Tax and NCI ($m) 234 175 110 113% 664 360 84% Core Net Profit after Tax and NCI (THBm) 7,463

%. The company reported FY17 sales revenue of THB 19,472 million (up 13%yoy), while the company showed FY17 EBITDA of THB 1,138 million (down 22%yoy). In addition, GGC has recognized profit of THB 88

27.2% in Q1’2018 because of 1) slight increasing of selling price per unit to from a slow adjustment of Ft charge but an 18.7% increase in gas cost and 2) y-on-y higher scheduled maintenance. However